Login / Signup

Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations.

Myrto KostopoulouChetan B MukhtyarGeorge K BertsiasDimitrios T BoumpasAntonis Fanouriakis
Published in: Annals of the rheumatic diseases (2024)
Anifrolumab and belimumab achieve better disease control than standard of care in extrarenal SLE, while combination therapies with belimumab and voclosporin attained higher response rates in high-quality RCTs in LN. Remission and low disease activity are associated with favourable long-term outcomes. In patients achieving these targets, GC and immunosuppressive therapy may gradually be tapered. Cite Now.
Keyphrases